Logiscreen

Perrigo Company plc

$10.83
Market Cap 1.49B
ROE -50.7%
Gross Margin 33.6%
Debt/Equity 1.5
Current Ratio 2.7
Revenue QoQ -7.2%
EPS QoQ 56.4%
F-Score 3

About

Perrigo Company plc is a leading pure-play consumer health company with over a century of experience in providing high-quality health and wellness solutions to consumers primarily in North America and Europe. As a pioneer in the over-the-counter (OTC) self-care market, Perrigo offers trusted self-care solutions that can be used without the need for a prescription, ensuring accessibility and choice for consumers across molecules, dosage forms, and value tiers. Perrigo's unique business model leverages its complementary businesses, where cash-generative store brand private label offerings fuel investments for leading brands, including Opill ®, Mederma ®, Compeed ®, EllaOne ®, and Jungle Formula ®.

Exchange
NYSE
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Sector context

Healthcare

Undervalued

Trading at a discount to sector peers

P/E
-0.81
vs median 33.61
P/B
0.59
vs median 2.16
ROE
-0.51
vs median 0.09

Lower quality - review fundamentals carefully

Small-cap company with higher volatility

Similar companies

Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics